Metabolomics in epidemiology: Sources of variability in metabolite measurements and implications

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 4, 2013, Pages 631-640

  Sampson, Joshua N ^a   Boca, Simina M ^a   Shu, Xiao Ou ^b,c   Stolzenberg Solomon, Rachael Z ^a   Matthews, Charles E ^a   Hsing, Ann W ^d,e   Tan, Yu Ting ^f   Ji, Bu Tian ^a   Chow, Wong Ho ^g   Cai, Qiuyin ^b,c   Liu, Da Ke ^f   Yang, Gong ^b,c   Xiang, Yong Bing ^f   Zheng, Wei ^b,c   Sinha, Rashmi ^a   Cross, Amanda J ^a   Moore, Steven C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

^d CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^e STANFORD CANCER INSTITUTE   (United States)

^f SHANGHAI CANCER INSTITUTE   (China)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ARACHIDONOYLGLYCEROPHOSPHOCHOLINE; 1,5 ANHYDROSORBITOL; 2 HYDROXYBUTYRIC ACID; 21 HYDROXYPREGNENOLONE DISULFATE; 3 (4 HYDROXYPHENYL)LACTATE; 3 DEHYDROCARNITINE; 4 ANDROSTEN 3BETA 17BETA DIOL DISULFATE 1; 4 ANDROSTEN 3BETA 17BETA DIOL DISULFATE 2; 4 ANDROSTENEDIOL; 5ALPHA ANDROSTAN 3BETA DIOL DISULFATE; ALPHA HYDROXYISOVALERATE; ANDRO STEROID MONOSULFATE 2; ANDROSTERONE; BIOLOGICAL MARKER; CREATINE; EPIANDROSTERONE; GLUTAROYL CARNITINE; GLYCOSYLTRYPTOPHAN; PRASTERONE SULFATE; PREGNEN DIOL DISULFATE; PREGNEN STEROID MONOSULFATE; PSEUDOURIDINE; PYROGLUTAMINE; UNCLASSIFIED DRUG; UNDECANOIC ACID; URATE;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CANCER RISK; CANCER SCREENING; EATING HABIT; EPIDEMIOLOGY; FEMALE; FOOD INTAKE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RELIABILITY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHROMATOGRAPHY, GAS; CHROMATOGRAPHY, LIQUID; COHORT STUDIES; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; METABOLOMICS; MIDDLE AGED; NEOPLASMS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 84876543322     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-1109     Document Type: Article

References (41)

1. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, et al. HMDB: the human metabolome database. Nucleic Acids Res 2007;35: D521-6. (Pubitemid 46056263)
2. Nicholson JK, Wilson ID. Understanding 'Global' systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov 2003;2:668-76. (Pubitemid 37361770)
3. Dettmer K, Aronov PA, Hammock BD. Mass spectrometry-based metabolomics. Mass Spectrom Rev 2007;26:51-78. (Pubitemid 46051813)
4. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, et al. Metabolite profiles and the risk of developing diabetes. Nat Med 2011;17:448-53.
5. Suhre K, Meisinger C, Döring A, Altmaier E, Belcredi P, Gieger C, et al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS ONE 2010;5:e13953.
6. Abate-Shen C, Shen MM. Diagnostics: the prostate-cancer metabolome. Nature 2009;457:799-800.
7. Jansson J,Willing B, LucioM, Fekete A, Dicksved J,Halfvarson J, et al. Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS ONE 2009;4:e6386.
8. Dodd KW, Guenther PM, Freedman LS, Subar AF, Kipnis V, Midthune D, et al. Statistical methods for estimating usual intake of nutrients and foods: a review of the theory. J Am Diet Assoc 2006;106:1640-50. (Pubitemid 44415594)
9. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982;38:963-74.
10. Carroll RJ. Measurement error in epidemiologic studies. Encyclopedia of Biostatistics. New York: John Wiley & Sons, Ltd.; 2005.
11. Nicholson G, Rantalainen M, Maher AD, Li JV, Malmodin D, Ahmadi KR, et al. Human metabolic profiles are stably controlled by genetic and environmental variation. Mol Syst Biol 2011;7:525.
12. Norman AW. Sunlight, season, skin pigmentation, vitamin D, and 25- hydroxyvitamin D: integral components of the vitamin D endocrine system. Am J Clin Nutr 1998;67:1108-10. (Pubitemid 28259494)
13. Lee SJ, Lenton EA, Sexton L, Cooke ID. The effect of age on the cyclical patterns of plasma LH, FSH, oestradiol and progesterone in women with regular menstrual cycles. Hum Reprod 1988;3: 851-5.
14. Wallace M, Hashim YZ, Wingfield M, Culliton M, McAuliffe F, Gibney MJ, et al. Effects of menstrual cycle phase on metabolomic profiles in premenopausal women. Hum Reprod 2010;25:949-56.
15. Katz FH, Romfh P, Smith JA, Roper EF, Barnes JS, Boyd JB. Diurnal variation of plasma aldosterone, cortisol and renin activity in supine man. J Clin Endocrinol Metab 1975;40:125-34.
16. Secor S. Specific dynamic action: a review of the postprandial metabolic response. J Comp Physiol B 2009;179:146-52.
17. Kaplan RC, Ho GYF, Xue X, Rajpathak S, Cushman M, Rohan TE, et al. Within-individual stability of obesity-related biomarkers among women. Cancer Epidemiol Biomarkers Prev 2007;16:1291-3. (Pubitemid 46984974)
18. Kotsopoulos J, Tworoger SS, Campos H, Chung F-L, Clevenger CV, Franke AA, et al. Reproducibility of plasma, red blood cell, and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev 2010;19:938-46.
19. Shah SH, Hauser ER, Bain JR, Muehlbauer MJ, Haynes C, Stevens RD, et al. High heritability of metabolomic profiles in families burdened with premature cardiovascular disease. Mol Syst Biol 2009;5:258-64.
20. Floegel A, Drogan D, Wang-Sattler R, Prehn C, Illig T, Adamski J, et al. Reliability of serum metabolite concentrations over a 4-month period using a targeted metabolomic approach. PLoS ONE 2011;6: e21103.
21. Peters TM, Moore SC, Xiang YB, Yang G, Shu XO, Ekelund U, et al. Accelerometer-measured physical activity in chinese adults. Am J Prev Med 2010;38:583-91.
22. Peters TM, Shu X-O, Moore SC, Xiang YB, Yang G, Ekelund U, et al. Validity of a physical activity questionnaire in Shanghai. Med Sci Sports Exerc 2010;42:2222-30.
23. Zheng W, Chow W-H, Yang G, Jin F, Rothman N, Blair A, et al. The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol 2005;162:1123-31. (Pubitemid 41746625)
24. Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, David Crawford E, et al. Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 2000;21:273S-309S.
25. Hayes RB, Reding D, Kopp W, Subar AF, Bhat N, Rothman N, et al. Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 2000;21: 349S-55S.
26. Yu Z, Kastenmüller G, He Y, Belcredi P, Möller G, Prehn C, et al. Differences between human plasma and serum metabolite profiles. PLoS ONE 2011;6:e21230.
27. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009;457:910-4.
28. Suhre K, Shin S-Y, Petersen A-K, Mohney RP, Meredith D, Wagele B, et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature 2011;477:54-60.
29. Lacher DA, Hughes JP, Carroll MD. Estimate of biological variation of laboratory analytes based on the third National Health and Nutrition Examination Survey. Clin Chem 2005;51:450-2. (Pubitemid 40175818)
30. Fraser CG, Petersen PH. Desirable standards for laboratory tests if they are to fulfill medical needs. Clin Chem 1993;39:1447-53.
31. Nieman DC, Gillitt ND, Henson DA, Sha W, Shanely RA, KnabAM, et al. Bananas as an energy source during exercise: a metabolomics approach. PLoS ONE 2012;7:e37479.
32. Kabat GC, Kim M, Caan BJ, Chlebowski RT, Gunter MJ, Ho GYF, et al. Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int J Cancer 2009;125:2704-10.
33. Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C, Speizer FE. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev 1995;4:649-54.
34. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, et al. Insulin, insulin-like growth factor-i, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2009;101:48-60.
35. James RE, Lukanova A, Dossus L, Becker S, Rinaldi S, Tjoønneland A, et al. Postmenopausal serum sex steroids and risk of hormone receptor- positive and -negative breast cancer: a nested case-control study. Cancer Prev Res 2011;4:1626-35.
36. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, DuGar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011;472:57-63.
37. Boffetta P, Clark S, Shen M, Gislefoss R, Peto R, Andersen A. Serum cotinine level as predictor of lung cancer risk. Cancer Epidemiol Biomarkers Prev 2006;15:1184-8.
38. Trygg J, Wold S. Orthogonal projections to latent structures (O-PLS). J Chemom 2002;16:119-28.
39. Shih WJ, Bachorik PS, Haga JA, Myers GL, Stein EA. Estimating the long-term effects of storage at -70-C on cholesterol, triglyceride, and HDL-cholesterol measurements in stored sera. Clin Chem 2000;46: 351-64. (Pubitemid 30152261)
40. Rundle AG, Vineis P, Ahsan H. Design options for molecular epidemiology research within cohort studies. Cancer Epidemiol Biomarkers Prev 2005;14:1899-907. (Pubitemid 41161198)
41. Tworoger SS, Hankinson SE. Collection, processing, and storage of biological samples in epidemiologic studies: sex hormones, carotenoids, inflammatory markers, and proteomics as examples. Cancer Epidemiol Biomarkers Prev 2006;15:1578-81. (Pubitemid 44497089)